Global Canine Stem Cell Therapy 麻豆原创 Research Report 2023

Publication ID:

PB504230964

Publication Date:

April 12, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Animal stem cell therapy is a usage of animal鈥檚 stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.
Highlights
The global Canine Stem Cell Therapy market was valued at US$ 64 million in 2022 and is anticipated to reach US$ 79 million by 2029, witnessing a CAGR of 3.7% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
麻豆原创 competition is intense. Medivet Biologics LLC, VETSTEM BIOPHARMA and J-ARM, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption region of animal stem cell therapy, with a consumption market share nearly 58%. Japan is the second largest supplier of animal stem cell therapy, enjoying production market share nearly 15%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Canine Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Stem Cell Therapy.
The Canine Stem Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Canine Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
Segment by Type
Allogeneic Stem Cells
Autologous Stem cells
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Stem Cell Therapy companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Canine Stem Cell Therapy 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Allogeneic Stem Cells
1.2.3 Autologous Stem cells
1.3 麻豆原创 by Application
1.3.1 Global Canine Stem Cell Therapy 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Veterinary Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Stem Cell Therapy 麻豆原创 Perspective (2018-2029)
2.2 Canine Stem Cell Therapy Growth Trends by Region
2.2.1 Global Canine Stem Cell Therapy 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Canine Stem Cell Therapy Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Canine Stem Cell Therapy Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Canine Stem Cell Therapy 麻豆原创 Dynamics
2.3.1 Canine Stem Cell Therapy Industry Trends
2.3.2 Canine Stem Cell Therapy 麻豆原创 Drivers
2.3.3 Canine Stem Cell Therapy 麻豆原创 Challenges
2.3.4 Canine Stem Cell Therapy 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Stem Cell Therapy Players by Revenue
3.1.1 Global Top Canine Stem Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Canine Stem Cell Therapy Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Canine Stem Cell Therapy 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Canine Stem Cell Therapy Revenue
3.4 Global Canine Stem Cell Therapy 麻豆原创 Concentration Ratio
3.4.1 Global Canine Stem Cell Therapy 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Stem Cell Therapy Revenue in 2022
3.5 Canine Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Canine Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Canine Stem Cell Therapy 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Stem Cell Therapy Breakdown Data by Type
4.1 Global Canine Stem Cell Therapy Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Canine Stem Cell Therapy Forecasted 麻豆原创 Size by Type (2024-2029)
5 Canine Stem Cell Therapy Breakdown Data by Application
5.1 Global Canine Stem Cell Therapy Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Canine Stem Cell Therapy Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Canine Stem Cell Therapy 麻豆原创 Size (2018-2029)
6.2 North America Canine Stem Cell Therapy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Canine Stem Cell Therapy 麻豆原创 Size by Country (2018-2023)
6.4 North America Canine Stem Cell Therapy 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Canine Stem Cell Therapy 麻豆原创 Size (2018-2029)
7.2 Europe Canine Stem Cell Therapy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Canine Stem Cell Therapy 麻豆原创 Size by Country (2018-2023)
7.4 Europe Canine Stem Cell Therapy 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Canine Stem Cell Therapy 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Canine Stem Cell Therapy 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Canine Stem Cell Therapy 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Canine Stem Cell Therapy 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Canine Stem Cell Therapy 麻豆原创 Size (2018-2029)
9.2 Latin America Canine Stem Cell Therapy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Canine Stem Cell Therapy 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Canine Stem Cell Therapy 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Stem Cell Therapy 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Canine Stem Cell Therapy 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Canine Stem Cell Therapy 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Canine Stem Cell Therapy 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 VETSTEM BIOPHARMA
11.1.1 VETSTEM BIOPHARMA Company Detail
11.1.2 VETSTEM BIOPHARMA Business Overview
11.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Introduction
11.1.4 VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.1.5 VETSTEM BIOPHARMA Recent Development
11.2 Cell Therapy Sciences
11.2.1 Cell Therapy Sciences Company Detail
11.2.2 Cell Therapy Sciences Business Overview
11.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Introduction
11.2.4 Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.2.5 Cell Therapy Sciences Recent Development
11.3 Regeneus
11.3.1 Regeneus Company Detail
11.3.2 Regeneus Business Overview
11.3.3 Regeneus Canine Stem Cell Therapy Introduction
11.3.4 Regeneus Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.3.5 Regeneus Recent Development
11.4 Aratana Therapeutics
11.4.1 Aratana Therapeutics Company Detail
11.4.2 Aratana Therapeutics Business Overview
11.4.3 Aratana Therapeutics Canine Stem Cell Therapy Introduction
11.4.4 Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.4.5 Aratana Therapeutics Recent Development
11.5 Medivet Biologics
11.5.1 Medivet Biologics Company Detail
11.5.2 Medivet Biologics Business Overview
11.5.3 Medivet Biologics Canine Stem Cell Therapy Introduction
11.5.4 Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.5.5 Medivet Biologics Recent Development
11.6 Okyanos
11.6.1 Okyanos Company Detail
11.6.2 Okyanos Business Overview
11.6.3 Okyanos Canine Stem Cell Therapy Introduction
11.6.4 Okyanos Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.6.5 Okyanos Recent Development
11.7 Vetbiologics
11.7.1 Vetbiologics Company Detail
11.7.2 Vetbiologics Business Overview
11.7.3 Vetbiologics Canine Stem Cell Therapy Introduction
11.7.4 Vetbiologics Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.7.5 Vetbiologics Recent Development
11.8 VetMatrix
11.8.1 VetMatrix Company Detail
11.8.2 VetMatrix Business Overview
11.8.3 VetMatrix Canine Stem Cell Therapy Introduction
11.8.4 VetMatrix Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.8.5 VetMatrix Recent Development
11.9 Magellan Stem Cells
11.9.1 Magellan Stem Cells Company Detail
11.9.2 Magellan Stem Cells Business Overview
11.9.3 Magellan Stem Cells Canine Stem Cell Therapy Introduction
11.9.4 Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.9.5 Magellan Stem Cells Recent Development
11.10 ANIMAL CELL THERAPIES
11.10.1 ANIMAL CELL THERAPIES Company Detail
11.10.2 ANIMAL CELL THERAPIES Business Overview
11.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Introduction
11.10.4 ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.10.5 ANIMAL CELL THERAPIES Recent Development
11.11 Stemcellvet
11.11.1 Stemcellvet Company Detail
11.11.2 Stemcellvet Business Overview
11.11.3 Stemcellvet Canine Stem Cell Therapy Introduction
11.11.4 Stemcellvet Revenue in Canine Stem Cell Therapy Business (2018-2023)
11.11.5 Stemcellvet Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.